ValbiotisXPAR:ALVAL +1.67%60 Receivables Turnover is 5.36 as of Dec. 2025. GuruFocus rates XPAR:ALVAL with a GF Score™ of 60/100 and a GF Value™ of €1.48 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,940 Consumer Packaged Goods companies, Valbiotis ranks worse than 56.34% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Valbiotis's Revenue for the
six
months ended in Dec. 2025 was €0.57 Mil. Valbiotis's average Accounts Receivable for the
six
months ended in Dec. 2025 was €0.11 Mil.
Hence, Valbiotis's Receivables Turnover for the
six
months ended in Dec. 2025 was 5.36.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Valbiotis Receivables Turnover Related Terms
Valbiotis Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Valbiotis's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALVAL vs KHC, GIS, HRL: Receivables Turnover Comparison
For the Packaged Foods subindustry, Valbiotis's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valbiotis Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Valbiotis's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Valbiotis's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valbiotis (XPAR:ALVAL) has a Receivables Turnover of 5.36 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Valbiotis and its competitors. According to the industry distribution chart, Valbiotis ranks #1093 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 56.3%.
Is Valbiotis' Receivables Turnover too high?
Valbiotis' current Receivables Turnover is 5.36. The Consumer Packaged Goods industry median Receivables Turnover is 9.36. Valbiotis' value of 5.36 is 42.7% below this industry median. Based on the distribution chart, Valbiotis ranks #1093 out of 1940 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Valbiotis has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valbiotis' Receivables Turnover compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Valbiotis ranks #1093 out of 1940 companies for Receivables Turnover. This places Valbiotis in the lower half of its industry. The industry median Receivables Turnover is 9.36. Valbiotis' value of 5.36 is 42.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.36, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valbiotis's current Receivables Turnover of 5.36 is 42.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Valbiotis and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valbiotis's current Receivables Turnover is 5.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valbiotis stock overvalued right now?
Based on GuruFocus' analysis, Valbiotis (XPAR:ALVAL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.48, compared to a current price of €0.79 — trading 46.6% below its estimated fair value. The current Receivables Turnover is 5.36 and 42.7% below the Consumer Packaged Goods industry median of 9.36. Valbiotis' overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Valbiotis (XPAR:ALVAL), the current Receivables Turnover is 5.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valbiotis (XPAR:ALVAL) Overvalued in 2026?
Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued.
The current stock price of €0.79 is trading 46.6% below its estimated GF Value™ of €1.48.
GuruFocus considers Valbiotis to be Possible Value Trap.
Key valuation signals for XPAR:ALVAL:
Receivables Turnover: 5.36
GF Value™: €1.48 vs. price of €0.79 (46.6% below fair value)
Industry Position: 42.7% below the Consumer Packaged Goods median (#1093 of 1940)
No single metric tells the full story. See the XPAR:ALVAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
60GF Score
Get the complete analysis for XPAR:ALVAL
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALVAL has been successfully added to your 
